| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.3 |